Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Repeat-Dose Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy Smokers.

Trial Profile

Repeat-Dose Pharmacokinetic and Pharmacodynamic Evaluation of Cytisine in Healthy Smokers.

Discontinued
Phase of Trial: Phase I/II

Latest Information Update: 14 Feb 2019

At a glance

  • Drugs Cytisine (Primary)
  • Indications Smoking withdrawal
  • Focus Pharmacodynamics; Pharmacokinetics
  • Sponsors Achieve Life Sciences
  • Most Recent Events

    • 05 Feb 2019 Status changed from recruiting to discontinued.
    • 19 Dec 2018 Planned End Date changed from 15 Nov 2018 to 30 Jan 2019.
    • 19 Dec 2018 Planned primary completion date changed from 15 Oct 2018 to 15 Jan 2019.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top